Amery A, De Plaen J F, Lijnen P, McAinsh J, Reybrouck T
Clin Pharmacol Ther. 1977 Jun;21(6):691-9. doi: 10.1002/cpt1977216691.
Thirty-five hypertensive patients were treated with atenolol in weekly increasing doses (25, 50, 100, and 200 mg thrice daily). Factors determining the blood level of the drug were studied along with the relationship between blood level, the degree of cardiac beta blockade, and the antihypertensive effect of the drug. The blood level obtained varied with the daily dose, the time of blood sampling during the day, the body weight, and the creatinine clearance. The degree of beta blockade was assessed by measuring maximum-exercise tachycardia and was correlated with the blood level of atenolol. The reduction of the maximum exercise heart rate was independent of age. The hypotensive effect was not closely correlated with the blood level. Three days after the termination of long-term atenolol treatment, blood levels and beta blockage were still detectable.
35名高血压患者接受阿替洛尔治疗,每周递增剂量(每日三次,每次25、50、100和200毫克)。探讨了决定药物血药浓度的因素,以及血药浓度与心脏β受体阻滞程度和药物降压效果之间的关系。所获得的血药浓度随每日剂量、白天采血时间、体重和肌酐清除率而变化。通过测量最大运动心率评估β受体阻滞程度,并将其与阿替洛尔血药浓度相关联。最大运动心率的降低与年龄无关。降压效果与血药浓度并无密切关联。长期阿替洛尔治疗终止三天后,仍可检测到血药浓度和β受体阻滞情况。